CDSCO Advisory on Painkiller Antibiotic Kidney Risk
Analysis based on 23 articles · First reported Sep 22, 2026 · Last updated Sep 23, 2026
The advisory raises compliance costs and regulatory scrutiny for India's pharmaceutical retailers, distributors and makers of NSAIDs and antibiotics, potentially dampening near-term over-the-counter painkiller and antibiotic volumes. However, it is unlikely to materially move broad equity indices, with impact concentrated in pharma and pharmacy retail names and a modest negative sentiment tilt for the sector.
The India — Central Drugs Standard Control Organisation issued a public advisory circular, dated September 21, warning against the indiscriminate, repeated or prolonged use of painkillers, particularly non-steroidal anti-inflammatory drugs (NSAIDs), and antibiotics, citing a heightened risk of Chronic Kidney Disease and antimicrobial resistance. The advisory, issued under the India — Directorate General of Health Services and attributed to Drugs Controller General of India Rajeev Singh Raghuvanshi, directs the general public, healthcare professionals, pharmacists, retailers, distributors, hospitals and state drug-control authorities to ensure rational, supervised use of these medicines. It reiterates that most NSAIDs fall under Schedule H and most antibiotics under Schedule H1 of the Drugs Rules, 1945, and therefore cannot be sold at retail without a prescription from a Registered Medical Practitioner. The public is advised against self-medication, sharing or reusing leftover antibiotics, and against using antibiotics for uncomplicated viral infections. Doctors are urged to prescribe only when clinically indicated, using the lowest effective dose for the shortest duration, with extra caution for patients with renal impairment, dehydration or cardiovascular disease, and to follow antimicrobial stewardship principles. Pharmacists and retailers are directed not to facilitate self-medication, while hospitals are asked to strengthen prescription review and monitoring systems. State and Union Territory drug-control authorities have been requested to raise awareness and ensure compliance with the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945. The Bangladesh — Ministry of Health and Family Welfare framed the warning as a measure to reduce avoidable kidney complications and protect antibiotic effectiveness.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard